Results 81 to 90 of about 46,671 (223)

Botulinum neurotoxin formulations: overcoming the confusion

, 2018
Souphiyeh Samizadeh,1 Koenraad De Boulle2 1Great British Academy of Aesthetic Medicine, London, UK; 2Aalst Dermatology Clinic, Aalst, Belgium Abstract: Botulinum toxin A is produced by anaerobic spore-forming bacteria and is used for various therapeutic ...
De Boulle K, Samizadeh S
core  

Structure of dual receptor binding to botulinum neurotoxin B

, 2013
Botulinum neurotoxins are highly toxic, and bind two receptors to achieve their high affinity and specificity for neurons. Here we present the first structure of a botulinum neurotoxin bound to both its receptors.
Dong, M., Stenmark, P., Peng, Lisheng, Dong, Min, Stenmark, Pål,, Berntsson, R.P. A., Berntsson, Ronnie P. A.,, Peng, L.   +7 more
core   +1 more source

Lysozyme gene treatment in testosterone induced benign prostate hyperplasia rat model and comparasion of its’ effectiveness with botulinum toxin injection

International Brazilian Journal of Urology
Objectives: To compare the effects and histopathological changes of botulinum neurotoxin type A and lysozyme gene injections into prostate tissue within a testosterone induced benign prostate hyperplasia rat model.
Osman Ergün, Pinar Aslan Koşar, İbrahim Onaran, Hakan Darici, Alim Koşar   +4 more
doaj   +1 more source

How Can We Personalize the Delivery of Onabotulinumtoxin‐A for Patients With Neurogenic Lower Urinary Tract Dysfunction?

Neurourology and Urodynamics, Volume 45, Issue 8, Page 1500-1506, November 2026.
ABSTRACT Background & Aims Neurogenic lower urinary tract dysfunction (NLUTD) can produce bothersome urinary symptoms, impact quality of life, and in some cases, lead to deterioration of upper urinary tract function. Intradetrusor injection of onabotulinumtoxin‐A (BoNT‐A) is approved for NLUTD in patients who have an inadequate response to or ...
Shirley L. Wang, William I. Jaffe, Ariana L. Smith   +2 more
wiley   +1 more source

Comparison of botulinum neurotoxin type A formulations in Asia

, 2018
Jürgen Frevert,1 Ki Young Ahn,2 Mee Young Park,3 Owen Sunga4 1Merz Pharmaceuticals GmbH, Frankfurt, Germany; 2Dr. Ahn’s Plastic and Aesthetic Surgical Clinic, Daegu, South Korea; 3Department of Neurology, Yeungnam University School of Medicine,
Ahn KY, Park MY, Frevert J, Sunga O
core  

Uso da toxina botulínica no controle do bruxismo [PDF]

, 2014
TCC (graduação) - Universidade Federal de Santa Catarina. Centro de Ciências da Saúde. Odontologia.A toxina botulínica é uma substância produzida pela bactéria Clostridium botulinum, e o seu uso oferece ao cirurgião dentista uma nova alternativa para ...
Francescon, Ariane
core  

Neurologic uses of botulinum neurotoxin type A

, 2007
John P Ney, Kevin R JosephMadigan Army Medical Center, Neurology Service, Tacoma, WA, USAAbstract: This article reviews the current and most neurologic uses of botulinum neurotoxin type A (BoNT-A), beginning with relevant historical data, neurochemical ...
Kevin R Joseph, John P Ney
core  

Botulinum neurotoxin to treat chronic anal fissure: results of a randomized "Botox vs. Dysport" controlled trial

, 2004
Botulinum neurotoxin induces healing in patients with idiopathic fissure.
Albanese, A, Cadeddu, F, Brisinda, G, Bentivoglio, A, Mabisombi, A, Maria, G., CADEDDU, FEDERICA, Marniga, G, Maria, G   +8 more
core   +1 more source

An Ultrasensitive Gold Nanoparticle-based Lateral Flow Test for the Detection of Active Botulinum Neurotoxin Type A

Nanoscale Research Letters, 2017
Botulism is a severe and potentially lethal paralytic disease caused by several botulinum neurotoxin-producing Clostridia spp. In China, the majority of the cases caused by botulism were from less-developed rural areas.
Jing Liu, Shan Gao, Lin Kang, Bin Ji, Wenwen Xin, Jingjing Kang, Ping Li, Jie Gao, Hanbin Wang, Jinglin Wang, Hao Yang   +10 more
doaj   +1 more source

Evaluation of a Multipolar MEMS Based Low‐Power Radiofrequency Device for Pain‐Free Facial Rejuvenation: A Prospective Clinical Study

Journal of Cosmetic Dermatology, Volume 25, Issue 11, November 2026.
ABSTRACT Background Noninvasive radiofrequency (RF) therapy has emerged as a prominent approach for facial rejuvenation due to its ability to stimulate collagen remodeling without epidermal ablation. However, conventional RF systems often rely on high thermal output, posing risks of heat‐induced dermal damage. Objective This study aimed to evaluate the
Rongwei Mao, Shengshuo Yan, Aditi A. Sharma, Tony Shum, Yang Zhang   +4 more
wiley   +1 more source